In contrast, another series where 50 tumor samples were assayed with a polyclonal antibody SSTR2A was reported as positive in 44% of glioblastomas, while only 10% of anaplastic and none of diffuse astrocytomas showed positive immunostaining for SSTR2 [13]. The gene discussed is SSTR2; the disease is diffuse astrocytoma.